14 research outputs found
Nutritive Value of the Dromedary Camel Meat
The current study was conducted to spotlight on the nutritive value of the dromedary camel meat from different ages in Egypt. A total of 50 samples were randomly collected over a period of 10 months from the hindquarter (glutobicepis) muscle of male camel carcasses slaughtered at Assiut and Sharkia Governorates. The samples were divided into two groups according to the age: Group "A" for young age (1≤5 years) and Group "B" for old ages (5-8 years). All samples were subjected to a proximate analysis (moisture, protein, fat, ash, and carbohydrate). Only 16 samples from each age were analyzed for some minerals content (Ca, Fe, K, P, Na, and Mg) and for cholesterol, caloric value and conjugated linoleic acid (CLA) contents. The statistical analysis of the results declared the presence of a significant increase (p<0.01) in fat, ash, carbohydrate, energy, calcium, phosphorus, magnesium, iron, cholesterol and conjugated linoleic acid contents of the camel meat samples with an increasing age. Camel meat from different ages has high nutritive value and it contains considerable amount of protein, which is nearly similar or sometimes higher than other red meat. Pointing to cholesterol and conjugated linoleic acid (CLA) content of camel meat, the obtained mean values in young and old ages were 31.11, 3.19 and 50.63, 5.99 mg/100gm fat, respectively. In conclusion, meat from young camels could be healthier due to its lower fat and cholesterol content
Effect of inhibition of estrogen synthesis or blocking its receptors on male rabbit reproduction
Purpose: The present aimed to study the effects of tamoxifen and fadrozole on semen characteristics and fertility, besides we emphasized the relationship between brain estrogen and sexual behavior in male rabbits. Methods: Eighty rabbits allocated into four equal groups. The control injected with sesame oil; the second injected with estradiol; the third injected with tamoxifen and the fourth injected with fadrozole. Treatments done daily for 60 days. Ten rabbits from each group served artificial vagina for evaluation of semen and sexual behavior. The other ten served female rabbits for fertility test. Reproductive organ and brain weights recorded. Serum and testicular testosterone, serum and brain estradiol and testicular zinc and cholesterol levels assayed. Results: Tamoxifen caused decrease in all estimated parameters except it increased both sperm ab normalities percentage; testicular cholesterol content; time of reaction and time between two consecutive ejaculations. Fadrozole results were opposite to that of tamoxifen except it increased the time between two consecutive ejaculations and decreased brain estradiol level. Conclusion: Fadrozole may be improve male rabbits performance along with elevated testosterone evident highlighting the important played by testosterone in regulating male rabbit fertility and advocacy the postulate that testosterone effect is mediated in part by its aromatization to estradiol
Recommended from our members
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation
Comparative effects of using prebiotic, probiotic, synbiotic and acidifier on growth performance, intestinal microbiology and histomorphology of broiler chicks
This study investigated the effects of dietary prebiotics, probiotic, synbiotic and organic acid salt supplementation on broiler growth performance, intestinal microflora, and histomorphology. A total of 300 one-day- old broiler chicks were randomly assigned to 5 different treatments with 3 replicates including 20 birds each. The birds received the same basal diet based on corn-soybean meal, and additives included in the diet at 0 control, prebiotic (1 g/kg), probiotic (1 g/ kg), synbiotic (1 g/ kg), and acidifier (5 g/ kg). The body weight, weight gain, feed conversion, intestinal morphology and microbiology of birds showed significant (p<0.01) improvement with dietary pre, pro, synbiotic and organic acid salt supplementation from 0 to 21d, 22-42 d and from 0-41 d in comparison with the control group. Synbiotic followed by probiotic supplemented groups revealed the highest final body weight, weight gain, better feed conversion and the highest antibody response to Newcastle disease vaccine (NDV) vaccine in comparison with prebiotic and organic acids. Moreover, synbiotic followed by probiotic supplementation significantly improved intestinal morphology and intestinal microbial ecology than prebiotic, organic acids and control groups. In conclusion, we suggest the use of synbiotic followed by probiotic is preferable as efficient growth and health promoters for broilers in comparison with prebiotic and organic acids
The impact of dietary inclusion of silver nanoparticles on growth performance, intestinal morphology, caecal microflora, carcass traits and blood parameters of broiler chickens
We evaluated the fects of different levels of dietary silver nanoparticle (AgNP) powder on performance, intestinal microflora, carcass traits and blood parameters of broiler chickens. Three hundred seven-day-old Ross broiler chicks were randomly divided into five groups, each group replicated three times with 20 birds per replication. Chickens were fed the basal diet with 2.5, 5, 10 and 20 mg AgNPs per kg feed. Dietary inclusion of AgNPs improved the final body weight, cumulative weight gain and feed conversion ratio. The best broiler performance, carcass traits, and relative organ weights were observed in the group supplemented with 2.5 ppm AgNPs. Increasing the AgNP dose resulted in a significant decrease in the caecal lactose positive and enterococci bacteria populations, while lactobacilli counts were numerically increased. The silver residues in the breast and thigh muscle significantly increased (p < .05) in a dose-dependent manner. Dietary inclusion of AgNPs induced dose-dependent lesions in liver, kidney, spleen and duodenum tissues involving degeneration, necrosis, mononuclear infiltration and focal aggregation of inflammatory cells. In conclusion, despite its potential positive impacts on growth performance, carcass traits and caecal microbial population diversity at a dose of 2.5 ppm, dietary inclusion of AgNPs had the following negative effects on broilers: 1) silver residues in breast and thigh muscle, which may result in AgNPs transmission to consumers, and 2) cytotoxicity in intestinal, liver, spleen and kidney cells in a dose-dependent manner. Therefore, we suggest the use of lower doses of AgNPs (< 2.5 ppm diet) in poultry production in the future studies.HIGHLIGHTS Dietary inclusion of silver nanoparticles (AgNPs) in broiler diets more than 2.5 mg/kg diets had many negative effects represented by accumulation of silver residue in broiler meat and the possibility of transmission of nanosilver to consumers. AgNPs had a cytotoxic effect on intestine, liver, spleen and kidney cells in a dose-dependent manner in broilers and might be harmful to chicken and human health. Therefore, we do not recommend using AgNPs as a dietary growth promotor or antibacterial agent in broiler diets and their use and marketing should be controlled and restricted
A study on the prevalence of multidrug resistant food poisoning Salmonella spp. in camel meat and offal with a reduction trial using organic acids
Camel meat is an important source of red meat and essential amino acids in Egypt and other Arab countries. This study aimed at investigation of the prevalence of Salmonella spp. in the camel meat and offal (liver, and kidney) retailed in Zagazig city, Egypt. Besides, antibiogram of the recovered Salmonella spp. was screened. In addition, a reduction trial for Salmonella loads in the prepared camel meat ball using organic acids such as acetic and lactic acids or their combination. The obtained results revealed isolation of Salmonella spp., at 20% (12 out of 60 samples). With the highest prevalence in the liver (30%), followed by kidney (20%), and muscle (10%), respectively. Salmonella spp., that were isolated were identified serologically as S. Enteritidis (33.33%), S. Typhimurium (41.66%), S. Virchow (8.33%), and S. Apeyeme (16.66%). The recovered species showed marked multidrug resiatance with the highest resistance against erythromycin, oxacillin, clindamycin, ampicillin, and nalidixic acid. The use of acetic, lactic acids and their combination could significantly reduce Salmonella load in the camel meat samples. In conclusion, the use of organic acids, particularly a combination of acetic and lactic acids (1:1, 2%) is of a particular importance in reducing Salmonella load in the camel meat
Prevalence and Antimicrobial Susceptibility of Campylobacter Species with Particular Focus on the Growth Promoting, Immunostimulant and Anti-Campylobacter jejuni Activities of Eugenol and Trans-Cinnamaldehyde Mixture in Broiler Chickens
Campylobacter species (spp.) are one of the most important causes of human bacterial gastroenteritis in foods of animal origin. Recently, with the spread of multi-drug-resistant (MDR) and extensively drug-resistant (XDR) Campylobacter spp., natural alternative therapeutic methods are urgently required. Phytogenic active principles have gained considerable attention due to their proficiency to enhance gut health and, thereby, performance of broiler chickens. Thus, the current study aims to determine the prevalence and antimicrobial resistance of Campylobacter spp. of different chicken sources in Sharkia Governorate, Egypt, and to assess the growth-promoting, immunostimulant and antimicrobial effects of a mixture of eugenol and trans-cinnamaldehyde in an in vivo approach. A total of 101 (67.3%) campylobacter isolates was identified, according to both phenotypic and genotypic techniques. Moreover, all of the campylobacter isolates were resistant to erythromycin, trimethoprim/sulfamethoxazole, and ampicillin (100% each). Of note, a dietary supplementation of the mixture of eugenol and trans-cinnamaldehyde led to a significant improvement of the feed conversion ratio and body weight gain and a decrease in the cecal C. jejuni loads in the broilers challenged with XDR C. jejuni. Additionally, eugenol and the trans-cinnamaldehyde mixture had protective activities via the down-regulation of XDR C. jejuni (flaA, virB11 and wlaN) virulence genes and proinflammatory cytokines (TNF-α, IL-2, IL-6, and IL-8), and the up-regulation of anti-inflammatory cytokine IL-10. Thus, we recommend the usage of a mixture of eugenol and trans-cinnamaldehyde as an alternative to antimicrobials for the control and treatment of campylobacter infections
Prevalence and Antimicrobial Susceptibility of <i>Campylobacter</i> Species with Particular Focus on the Growth Promoting, Immunostimulant and Anti-<i>Campylobacter jejuni</i> Activities of Eugenol and Trans-Cinnamaldehyde Mixture in Broiler Chickens
Campylobacter species (spp.) are one of the most important causes of human bacterial gastroenteritis in foods of animal origin. Recently, with the spread of multi-drug-resistant (MDR) and extensively drug-resistant (XDR) Campylobacter spp., natural alternative therapeutic methods are urgently required. Phytogenic active principles have gained considerable attention due to their proficiency to enhance gut health and, thereby, performance of broiler chickens. Thus, the current study aims to determine the prevalence and antimicrobial resistance of Campylobacter spp. of different chicken sources in Sharkia Governorate, Egypt, and to assess the growth-promoting, immunostimulant and antimicrobial effects of a mixture of eugenol and trans-cinnamaldehyde in an in vivo approach. A total of 101 (67.3%) campylobacter isolates was identified, according to both phenotypic and genotypic techniques. Moreover, all of the campylobacter isolates were resistant to erythromycin, trimethoprim/sulfamethoxazole, and ampicillin (100% each). Of note, a dietary supplementation of the mixture of eugenol and trans-cinnamaldehyde led to a significant improvement of the feed conversion ratio and body weight gain and a decrease in the cecal C. jejuni loads in the broilers challenged with XDR C. jejuni. Additionally, eugenol and the trans-cinnamaldehyde mixture had protective activities via the down-regulation of XDR C. jejuni (flaA, virB11 and wlaN) virulence genes and proinflammatory cytokines (TNF-α, IL-2, IL-6, and IL-8), and the up-regulation of anti-inflammatory cytokine IL-10. Thus, we recommend the usage of a mixture of eugenol and trans-cinnamaldehyde as an alternative to antimicrobials for the control and treatment of campylobacter infections
Three species of Echinococcus granulosus sensu lato infect camels on the Arabian Peninsula
We report on the genetic identity of 36 Echinococcus cysts that were collected during a recent slaughterhouse survey of 810 locally bred camels (dromedaries) in the Eastern Province of the Kingdom of Saudi Arabia. Analysis of a partial nad1 gene sequence showed that the majority (n = 29) belonged to E. granulosus sensu stricto, four to E. canadensis G6/7, and three to E. ortleppi. Eight of the 29 E. granulosus s.s. cysts contained protoscoleces; all other cysts were calcified and non-viable. This is the first report of the presence E. ortleppi from the Arabian Peninsula, a parasite that is typically transmitted via cattle. The results indicate widespread infection of camels with CE in eastern Saudi Arabia and an active role of camels in the lifecycles of at least E. granulosus s.s.. Complete cox1 haplotype analysis of 21 E. granulosus s.s. isolates shows that the majority of variants circulating in eastern Saudi Arabia is distinct from but closely related to haplotypes from neighboring countries in the Middle East, which indicates the presence of this parasite in KSA for a longer period of time. All isolates of E. granulosus s.s. in this study belonged to the G1 cluster, although the G3 genotype has previously also been reported from the Middle East